- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Jim Cramer says the earnings results we get this week will determine where stocks are headed for the rest of the quarter.
The fluorescence imaging technology company has agreed to sell to Stryker for $11.75 per share.
The medical device maker will pay $701 million for NOVADAQ.